Care of the seriously ill neonate with hyaline membrane disease and with sepsis (sclerema neonatorum).
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D005260:Female; D005500:Follow-Up Studies; D005865:Gestational Age; D006801:Humans; D006819:Hyaline Membrane Disease / Q000453:epidemiology / Q000401:mortality / Q000451:nursing / Q000628:therapy*; D007231:Infant, Newborn; D007263:Infusions, Parenteral; D007362:Intensive Care Units; D008297:Male; D008991:Monitoring, Physiologic; D010102:Oxygen Inhalation Therapy; D011247:Pregnancy; D012121:Respiration, Artificial; D012124:Respiratory Care Units; D012593:Sclerema Neonatorum / Q000188:drug therapy / Q000453:epidemiology / Q000401:mortality / Q000451:nursing / Q000628:therapy*; D012737:Sex Factors; D013557:Switzerland; D013997:Time Factors; D014187:Transportation of Patients
D000900:Anti-Bacterial Agents